Treatment with Flutamide, Metformin, and Their Combination Added to a Hypocaloric Diet in Overweight-Obese Women with Polycystic Ovary Syndrome: A Randomized, 12-Month, Placebo-Controlled Study

Cited by (221)

Items 101–200 of 221

1. Targeting insulin sensitivity in the treatment of polycystic ovary syndrome
   Renato Pasquali, Alessandra Gambineri · 2009 · Expert Opinion on Therapeutic Targets
2. Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments
   Zuuren, E.J., Fedorowicz, Z. · 2016 · British Journal of Dermatology
3. Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model
   Maria Kupreeva, Abdoulaye Diané, Richard S. Lehner, Russell Watts, Mahua Ghosh, Spencer D. Proctor, Donna Faye Vine · 2018 · American Journal of Physiology-Endocrinology and Metabolism
4. The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta‐analysis
   Maddalena Barba, Holger Jens Schünemann, Francesca Sperati, Elie A. Akl, Felice Musicco, Gordon Henry Guyatt, Paola C. Muti · 2009 · Clinical Endocrinology
5. Low‐dose pioglitazone and low‐dose flutamide added to metformin and oestro‐progestagens for hyperinsulinaemic women with androgen excess: add‐on benefits disclosed by a randomized double‐placebo study over 24 months
   Lourdes Ibáñez, Abel López‐Bermejo, Marta Díaz, Goya Enríquez, Luis del Río, Francis de Zegher · 2008 · Clinical Endocrinology
6. Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls
   Alessandra Gambineri, Flaminia Fanelli, Federica Tomassoni, Alessandra Munarini, Uberto Pagotto, Ruth Andrew, Brian Robert Walker, Renato Pasquali · 2014 · European Journal of Endocrinology
7. Retrospective observational study on the effects and tolerability of flutamide in a large population of patients with various kinds of hirsutism over a 15-year period
   Roberto Paradisi, Stefano Venturoli · 2010 · European Journal of Endocrinology
8. Effects of metformin on blood lipid profiles in nondiabetic adults: a meta-analysis of randomized controlled trials
   Shuwei Weng, Yonghong Luo, Ziyu Zhang, Xin Su, Daoquan Peng · 2020 · Endocrine
9. Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome
   Sofia Lazaridou, K. Dinas, K. Tziomalos · 2017 · HORMONES
10. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis
    Anran Wang, Tingting Mo, Qiao Li, Chuangpeng Shen, Min Liu · 2019 · Endocrine
11. Effect of Metformin and Flutamide on Anthropometric Indices and Laboratory Tests in Obese/Overweight PCOS Women under Hypocaloric Diet.
    Mania Amiri, Masoumeh Golsorkhtabaramiri, Sedighe Esmaeilzadeh, Faeze Ghofrani, Ali Bijani, Leila Ghorbani, Mouloud Agajani Delavar · 2014 · PubMed Central
12. Pioglitazone (7·5 mg/day) added to flutamide–metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin
    Lourdes Ibáñez, Abel López‐Bermejo, Marta Díaz, Goya Enríquez, Carme Valls, Francis de Zegher · 2007 · Clinical Endocrinology
13. Adiposity and metabolic dysfunction in polycystic ovary syndrome
    Susan Sam · 2015 · Hormone Molecular Biology and Clinical Investigation
14. The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies
    Nikolaos Nikolaou, Leanne Hodson, Jeremy Tomlinson · 2021 · The Journal of Steroid Biochemistry and Molecular Biology
15. No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen‐secreting tumours
    Carla Pelusi, G Forlani, Laura Zanotti, Alessandra Gambineri, Renato Pasquali · 2012 · Clinical Endocrinology
16. Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome
    Isabel Huang‐Doran, Stephen Franks · 2016 · Frontiers in Endocrinology
17. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome
    Evanthia Diamanti‐Kandarakis, Eleni Kandaraki, Charikleia D. Christakou, Dimitrios Panidis · 2009 · Obesity Reviews
18. Randomized clinical trial: effect of low-dose flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome
    Daniel Anthony Dumesic, Chloe Winnett, Gwyneth Lu, Tristan Grogan, David Howard Abbott, Rajanigandha Naik, Gregorio Daniel Chazenbalk · 2022 · Fertility and Sterility
19. Effects of metformin on body weight in polycystic ovary syndrome patients: model-based meta-analysis
    Xiao Chen, Su‐Mei He, Dongdong Wang · 2020 · Expert Review of Clinical Pharmacology
20. Puberty in the Female and Its Disorders
    Robert L. Rosenfield, David W. Cooke, Sally Radovick · 2021 · Elsevier eBooks
21. How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology
    Paolo Moghetti, Enrico Carmina, Vincenzo De Leo, Antonio Lanzone, Francesco Orio, Riccardo Pasquali, Vincenzo Toscano · 2015 · Journal of Endocrinological Investigation
22. Targets to treat androgen excess in polycystic ovary syndrome
    Manuel Luque‐Ramírez, Héctor Francisco Escobar-Morreale · 2015 · Expert Opinion on Therapeutic Targets
23. The Relationship between Intake of Dairy Products and Polycystic Ovary Syndrome in Women Who Referred to Isfahan University of Medical Science Clinics in 2013.
    Golnaz Rajaeieh, Mohamadreza Marasi, Zahra Shahshahan, Fatemmeh Hassanbeigi, Seied Morteza Safavi · 2014 · PubMed Central
24. The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment
    Baldani, Dinka Pavicic, Skrgatic, Lana, Ougouag, Roya, Kasum, Miro · 2018 · Gynecological Endocrinology
25. Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
    Robert L. Rosenfield, Randall B. Barnes, David A. Ehrmann · 2015 · Elsevier eBooks
26. Key signalling pathways underlying the aetiology of polycystic ovary syndrome
    Kirsty A. Walters, Alba Moreno-Asso, Nigel K. Stepto, Michaël W. Pankhurst, Valentina Rodriguez Paris, Raymond Joseph Rodgers · 2022 · Journal of Endocrinology
27. Association between sex steroid hormones and subsequent hyperglycemia during pregnancy
    Ying Meng, Loralei Lacina Thornburg, Kathleen M. Hoeger, Zorimar Rivera‐Núñez, Amber Kautz, Adam T. Evans, Christina Wang, Richard Kermit Miller, Susan W. Groth, Thomas G. O’Connor et al. · 2023 · Frontiers in Endocrinology
28. Steroids and the metabolic syndrome
    Renato Pasquali, Valentina Vicennati · 2008 · The Journal of Steroid Biochemistry and Molecular Biology
29. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials
    Mohamed Abdel-Maboud, Amr Menshawy, Elfatih A. Hasabo, Mohamed Ibrahim Abdelraoof, Mohamed Alshandidy, Muhammad Eid, Esraa Menshawy, Oumaima Outani, Ahmed Menshawy · 2021 · PLoS ONE · Retracted
30. Effectiveness of long-term (twelve months) nonsurgical weight loss interventions for obese women with polycystic ovary syndrome: a systematic review
    Fiona Nicholson · 2010 · International Journal of Women s Health
31. Comparison of Finasteride, Metformin, and Finasteride Plus Metformin in PCOS
    Halit Diri · 2017 · Acta Endocrinologica (Bucharest)
32. Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
    Tao Long, Ying Zhang, Chun‐Ping Zeng, Siyuan Zheng, Lin Zhou, Haiyan Liu · 2022 · International Journal of Endocrinology
33. Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess
    Iolanda Lázaro, Marta Díaz, Anna Cabré, L. Masana, Lourdes Ibáñez · 2011 · Gynecological Endocrinology
34. Evidence-Based Lifestyle and Pharmacological Management of Infertility in Women with Polycystic Ovary Syndrome
    Michael Costello, William J. Ledger · 2012 · Women s Health
35. The Role of Androgen Excess in Metabolic Dysfunction in Women
    Héctor Francisco Escobar-Morreale · 2017 · Advances in experimental medicine and biology
36. POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Long-term health outcomes in polycystic ovary syndrome
    Anuja Dokras, Manuel Luque‐Ramírez, Héctor Francisco Escobar-Morreale · 2025 · Reproduction
37. Androgens and polycystic ovary syndrome
    Macarena Alpañés, Elena Fernández‐Durán, Héctor Francisco Escobar-Morreale · 2011 · Expert Review of Endocrinology & Metabolism
38. Metformin and polycystic ovary syndrome
    Tessa G Lebinger · 2007 · Current Opinion in Endocrinology Diabetes and Obesity
39. Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome
    Susan Sam, Priyathama Vellanki, Sudha K. Yalamanchi, Richard N. Bergman, Andrea Elizabeth Dunaif · 2017 · Metabolism
40. Committee Opinion No. 714: Obesity in Adolescents
    2017 · Obstetrics and Gynecology
41. Flutamide–metformin for post-menarcheal girls with preclinical ovarian androgen excess: evidence for differential response by androgen receptor genotype
    Ken K. Ong, Francis de Zegher, Abel López‐Bermejo, David B. Dunger, Lourdes Ibáñez · 2007 · European Journal of Endocrinology
42. The American Diabetes Association's 57th Annual Advanced Postgraduate Course
    Zachary T. Bloomgarden · 2010 · Diabetes Care
43. A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy
    Manuel Luque‐Ramírez, A.E. Ortiz-Flores, Lía Nattero‐Chávez, Héctor Francisco Escobar-Morreale · 2020 · Expert Opinion on Drug Safety
44. Age-Dependent Changes in the Effects of Androgens on Female Metabolic and Body Weight Regulation Systems in Humans and Laboratory Animals
    Takeshi Iwasa, Hiroki Noguchi, Risa Tanano, Erika Yamanaka, Asuka Takeda, Kou Tamura, Hidenori Aoki, Tatsuro Sugimoto, Hikari Sasada, Takaaki Maeda et al. · 2023 · International Journal of Molecular Sciences
45. Spironolactone Versus Oral Contraceptive Pills in the Treatment of Adolescent Polycystic Ovarian Syndrome: A Systematic Review
    Shriya Rajashekar, Suganya Giri Ravindran, Meghana Kakarla, Musa Ausaja Gambo, Mustafa Yousri Salama, Nathalie Haidar Ismail, Pardis Tavalla, Pulkita Uppal, Shaza A Mohammed, Pousette Hamid · 2022 · Cureus
46. Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
    Thomas Paterakis, Evanthia Diamanti‐Kandarakis · 2014 · Current Obesity Reports
47. Low-dose flutamide for women with androgen excess: Anti-androgenic efficacy and hepatic safety
    Francis de Zegher, Lourdes Ibáñez · 2009 · Journal of Endocrinological Investigation
48. Role of the AMP-Activated Protein Kinase in the Pathogenesis of Polycystic Ovary Syndrome
    Abduldaheem Turki Jalil, Mahdi Abd Zair, Zainab Rahi Hanthal, Sarmad Jaafar Naser, Tahani Aslandook, Munther Abosaooda, Ali A. Fadhil · 2023 · Indian Journal of Clinical Biochemistry
49. Anti-Müllerian Hormone: A Molecular Key to Unlocking Polycystic Ovary Syndrome?
    David Howard Abbott, Beverly A Hutcherson, Daniel Anthony Dumesic · 2024 · Seminars in Reproductive Medicine
50. On the Intimate Relationship of Adiposity to Polycystic Ovary Syndrome
    Robert L. Rosenfield, Daniel Anthony Dumesic · 2025 · The Journal of Clinical Endocrinology & Metabolism
51. Unraveling the multifactorial pathophysiology of polycystic ovary syndrome: exploring lifestyle, prenatal influences, neuroendocrine dysfunction, and post-translational modifications
    Harshini Senthilkumar, Subhash Chandra Chauhan, Mohanapriya Arumugam · 2025 · Molecular Biology Reports
52. The effects of conformation and intermolecular hydrogen bonding on the structure and IR spectra of flutamide; a study based on the matrix isolation technique, ab initio and DFT calculations
    C. Arman, Kubilay Balci, Y. Akkaya, Sevim Akyüz, T. Reaves-Mckee, A.H. Frankamp, Joel T. Coates, William B. Collier, Gary Ritzhaupt, C.E. Klehm et al. · 2023 · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
53. Sex Hormone Binding Globulin and Sex Steroids Among Premenopausal Women in the Diabetes Prevention Program
    Catherine Kim, Xavier Pi-Sunyer, Elizabeth L. Barrett-Connor, Frankie B. Stentz, Mary Beth Murphy, Shengchun Kong, Bin Nan, Abbas E. Kitabchi · 2013 · The Journal of Clinical Endocrinology & Metabolism
54. Polycystic ovary syndrome (PCOS): metformin.
    David J Cahill, Katherine O’Flynn O’Brien · 2015 · Europe PMC (PubMed Central)
55. Management of cardiometabolic complications in polycystic ovary syndrome: Unmet needs
    Licy L. Yanes Cardozo, Damián G. Romero · 2021 · The FASEB Journal
56. Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome
    Sarad Pawar Naik Bukke, Bharghava Bhushan Rao Pathange, Srikanth Kumar Karumanchi, Jalaiah Marri, Revathi Boyina, Kavya Rachamsetty, Bhargavi Manchikalapati, Saidi Odoma, Hussaini Bello · 2023 · Journal of Ovarian Research
57. Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome
    Sebastião Freitas de Medeiros, Bruna Barcelo Barbosa, Matheus Antônio Souto de Medeiros, Ana Karine Lin Winck Yamamoto, Márcia Marly Winck Yamamoto · 2022 · Revista Brasileira Ginecologia e Obstetrícia
58. Conceptual Biology Research Supporting Platform: Current Design and Future Directions
    Ying Xie, Jayasimha R. Katukuri, Vijay V. Raghavan, Tony Presti · 2008 · Studies in computational intelligence
59. Commentary: Testosterone and the metabolic syndrome: cause or consequence?
    Aled Rees, Colin Mark Dayan · 2010 · International Journal of Epidemiology
60. Sex hormones, obesity and type 2 diabetes-is there a link?
    Alessandra Gambineri · 2018 · Endocrine Abstracts
61. Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men
    Justine M. Mucinski, David E. Kelley, Stephen J. Winters, Bret H. Goodpaster · 2025 · Obesity
62. Effects of placebo‐controlled insulin‐sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta‐analysis
    Rong Huang, Peng‐Fei Zhao, Jianhua Xu, Dongdong Liu, Fudong Luo, Yong‐Hui Dai · 2017 · Journal of Cellular Biochemistry
63. Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis
    Tina Kaur Thethi, Bonnie Katalenich, Prathima Nagireddy, Pankdeep Chabbra, Nitesh D Kuhadiya, Vivian Andrew Fonseca · 2015 · Endocrine Practice
64. Metformin does not improve insulin sensitivity over hypocaloric diets in women with polycystic ovary syndrome: a systematic review of 12 studies
    Samantha Celeste Garcia-Hernandez, Leonardo M. Porchia, Blanca T. Pacheco-Soto, Esther López‐Bayghen, M. Elba González-Mejía · 2021 · Gynecological Endocrinology
65. Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
    Randall B. Barnes, David A. Ehrmann, Robert L. Rosenfield · 2010 · Elsevier eBooks
66. Androgen actions in metabolic tissues in polycystic ovary syndrome
    Caitlin L. MacRae, Rebecca E. Campbell · 2026 · Endocrinology
67. Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention
    Hamidreza Mani, Kamlesh Khunti, Miles J Levy, Melanie Jane Davies · 2013 · Diabetes Management
68. The effects of androgens on metabolic functions in females
    Takeshi Iwasa, Yuri Yamamoto, Akari Shinya, Saki Minato, Rie Yanagihara, Shuhei Kamada, Junki Imaizumi, Tomohiro Kagawa, Aya Shirakawa, Hiroki Noguchi et al. · 2021 · The Journal of Medical Investigation
69. Efficacy of Weight‐Lowering Agents on Fat Distribution: A Systematic Review and Network Meta‐Analysis of Randomized Controlled Trials
    Xiuqi Qiao, Weihao Wang, Jiaming Cao, Lixin Guo, Qi Pan · 2026 · Obesity Reviews
70. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
    Mohammed Altigani Abdalla, Najeeb Zaheer Shah, Harshal Deshmukh, Amirhossein Sahebkar, Linda Östlundh, Rami H. Al‐Rifai, Stephen Lawrence Atkin, Thozhukat Sathyapalan · 2022 · Archives of Gynecology and Obstetrics
71. The Endocrinological Basis for Polycystic Ovary Syndrome: An Evolutionary Perspective
    Daniel Anthony Dumesic, Bernard J. Crespi, Vasantha Padmanabhan, David Howard Abbott · 2025 · Endocrinology
72. Intrinsic abnormalities of adipose tissue and adipose tissue dysfunction in PCOS
    Poli Mara Spritzer, Betânia Rodrigues dos Santos, Tayane Muniz Fighera, Lucas Bandeira Marchesan, Sheila Bünecker Lecke · 2021 · Elsevier eBooks
73. Cardiovascular Health in Women—Across the Lifespan
    Jaya Chandrasekhar, Jessica Victoria Yao, Simone Gong, Pasangi Madhuka Wijayarathne, Monique Watts, Swati Mukherjee · 2025 · Clinical Endocrinology
74. The polycystic ovary syndrome: a position statement from the European Society of
    Gerard S. Conway, Didier Dewailly, Evanthia Diamanti‐Kandarakis, Stephen Franks, Alessandra Gambineri, Fahrettin Keleştimur, Djuro Μacut, Dragan Micić, Renato Pasquali, Marija Pfeifer et al. · 2014
75. The Association between Amino Acid Intake and Polycystic Ovary Syndrome in Women Who Referred to Isfahan University of Medical Science Clinics
    Glnaz Rajaeieh, Nafiseh Shokri Mashhadi, Morteza Safavi, Zahra Amini Pozveh, Ali Pezeshki · 2018 · Nutrition and Food Sciences Research
76. The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome
    Leyi Jiang, Jiaying Xiao, Liangzhen Xie, Feifei Zheng, Fangliang Ge, Xue Yan Zhao, Ruonan Qiang, Jie Fang, Zhinan Liu, Zihan Xu et al. · 2025 · Journal of Ovarian Research
77. PCOS Therapy
    Mariagrazia Stracquadanio, Lilliana Ciotta · 2015 · Springer eBooks
78. Ovarian Function and Obesity: PCOS, Menopause
    Carla Lubrano, Lucio Gnessi, Silvia Migliaccio · 2014 · Springer eBooks
79. Targeting UGT2B15 and NR1H4 interaction: a novel therapeutic strategy for polycystic ovary syndrome using naftopidil enantiomers
    Xiufen Zheng, Zikai Chen, Miao Liang, Liting Zhou, Miaoru Wang, Silin Zhang, Shuyun Zhang, Lei Ma, Wei Yi, Xiawen Liu · 2025 · Journal of Ovarian Research
80. Cardiometabolic risk in women with polycystic ovary syndrome: a comprehensive review
    Angelo Cagnacci, Gino A. ANTONELLI, Giulia VATTERONI, Anjeza Xholli · 2025 · Minerva Obstetrics and Gynecology
81. The pathogenic role of androgen excess in PCOS
    Duarte Pignatelli, Sofia Silva Pereira, Eleni Kandaraki · 2021 · Elsevier eBooks
82. Polycystic Ovary Syndrome and Obstructive Sleep Apnea
    Mira Aubuchon · 2007 · Humana Press eBooks
83. Hirsutismo y trastornos menstruales en la adolescencia
    Lourdes Ibáñez, María Victoria Marcos, Rubén Díaz · 2009 · Anales de Pediatría Continuada
84. Infertility in women with polycystic ovary syndrome and the role of metformin in management
    Jacqueline Anne Boyle, Helena Jane Teede, Marie L Misso · 2013 · Expert Review of Obstetrics & Gynecology
85. Reproduction and Metabolism: Insights from Polycystic Ovary Syndrome
    Prathima Jasti, Andrea Elizabeth Dunaif · 2012 · Endocrinology and Metabolism
86. Polycystic Ovary Syndrome: Pathogenesis, health consequences, and treatment of PCOS in relation to insulin resistance
    Danielle Bernier · 2012 · University of New Hampshire Scholars Repository (University of New Hampshire at Manchester)
87. Polycystic ovary syndrome: individualized approach to treatment. Literature review
    Л. А. Жабіцька · 2020 · Reproductive Endocrinology
88. Mechanisms and Treatment of Obesity in Polycystic Ovary Syndrome
    Renato Pasquali, Alessandra Gambineri · 2008 · Humana Press eBooks
89. Metabolic syndrome in patients with the polycystic ovary syndrome
    Dimitrios Panidis, Κωνσταντίνος Τζιόμαλος, Efstathios P. Papadakis · 2013 · Expert Review of Endocrinology & Metabolism
90. Serum Adiponectin levels in Different Phenotypes of Polycystic Ovary Syndrome
    Carolina Fux Otta, Paula Szafryk de Mereshian, Raquel Kaplan, Gabriel Santino Iraci, Silvia Ojeda, José Ochoa, Andrés Albrecht, Natalia Filipone, Marta Fiol de Cúneo · 2012 · Open Journal of Endocrine and Metabolic Diseases
91. Medical Treatment
    Jean‐Patrice Baillargeon, Nadir R. Farid · 2009 · Springer eBooks
92. Risk Prediction System for PCOS Disease Using Machine Learning
    Ch. Ramesh Babu, Raju Challagundla, P Kiran Kumar, S. Dilli Babu, J Suresh Babu, M. Sunil Kumar · 2025 · International Conference on Recent Advances in Information Technology
93. A multidisciplinary approach to polycystic ovary syndrome: synergy of methods
    Elena Nikolaevna Andreeva, Galina Afanas'evna Mel'nichenko, Maria Igorevna Yarmolinskaya, Marina Borisovna Khamoshina, Л. В. Сутурина, Бурумкулова Фатима Фархадовна, O. R. Grigoryan, Olga Yu. Sukhareva, Alena Viktorovna Tiselko, Svetlana Yu. Vorotnikova et al. · 2025 · Bulletin of Reproductive Health
94. Sex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention program
    Catherine Kim, Elizabeth L. Barrett-Connor, John F. Randolph, Shengchun Kong, Bin Nan, Kieren J. Mather, Sherita Hill Golden · 2013 · Obesity
95. Polycystic Ovary Syndrome and Obstructive Sleep Apnea
    Mira Aubuchon · 2020 · Current clinical neurology
96. Синдром поликистозных яичников. Официальное заявление Европейского общества эндокринологии
    Gerard S. Conway, Didier Dewailly, Evanthia Diamanti‐Kandarakis · 2015 · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy
97. Androgens and Cardiovascular Risk Factors in Polycystic Ovary Syndrome
    Licy L. Yanes Cardozo, Alexandra M Huffman, Jacob E. Pruett, Damián G. Romero · 2021 · IntechOpen eBooks
98. Polycystic ovary syndrome
    Roger A. Lobo · 2021 · Elsevier eBooks
99. Polycystic Ovary Syndrome and the Metabolic Syndrome
    Onno Eilard Janssen, Susanne Tan, Tiina Dietz, Susanne Hahn · 2007 · CRC Press eBooks
100. Interferenza della flutamide sulla differenziazione sessuale di un feto maschio. Descrizione di un caso
     Alfonsa Pizzo, Irene Borrielli, Emanuela Raffone, Alberto Vaiarelli, Narciso Carlo Stella · 2009